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Summary and Implications 
 The purpose of this research was to evaluate the use of 
an on-farm culture system in conjunction with the California 
Mastitis Test for the strategic treatment of subclinical 
mastitis in fresh cows and clinical mastitis. CMT showed 
high NPV indicating it was very effective in determining 
uninfected quarters. However, PPV were low resulting in 
many CMT+ quarters being uninfected; thus many 
uninfected quarters being treated also. Cure rates in both the 
fresh and clinical animals did not change when treatment 
was delayed for twenty-four hours while waiting for culture 
results This would indicate that waiting for culture results 
before instituting treatment does not affect treatment 
success. The on-farm culture system, in conjunction with 
the CMT, dramatically reduced the number of animals 
treated with antimicrobials as compared to basing treatment 
The purpose of this research is to evaluate the use of an on-
farm culture system in conjunction with the California 
Mastitis Test for the strategic treatment of subclinical 
mastitis in fresh cows and clinical mastitis. A cost-benefit 
analysis will also be used to determine the economic 
feasibility of an on-farm culture system for commercial use.  
 
Materials and Methods 
 Fresh Cow Protocol (Figure 1): Approximately 75 
animals calved between June and August at the Iowa State 
University Dairy Farm. Within twenty-four hours of 
calving, all fresh animals had a CMT performed on milk 
from all individual quarters. Aseptic quarter samples were 
also taken from all quarters and cultured for mastitis 
organisms using National Mastitis Council procedures. Milk 
from each quarter was initially swabbed on both blood and 
MacConkey agar plates and incubated at 37°C for twenty-
four hours at the dairy. Organisms that showed growth on 
both the blood and MacConkey agar were assumed to be 
gram negative, while organisms that grew only on the blood 
agar were assumed to be gram positive. Plates showing 
growth were submitted to the clinical microbiology lab at 
the Iowa State University College of Veterinary Medicine 
for identification and antibiotic susceptibility testing. 
Quarters and cows testing negative on the CMT received no 
other treatments. Cows that were CMT positive were 
randomly assigned to one of two treatment groups – blocked 
by first and other lactations. The first group (control) was 
immediately treated with the antimicrobial Pirlimycin 
hydrocholoride (Pirsue®, Pfizer, Inc) for two total 
treatments twenty-four hours apart in all CMT positive 
quarters. The second group (wait) was not treated until 
culture results became available twenty-four hours post 
CMT. Quarters with gram negative organisms or showing 
no growth were not treated. All quarters that cultured gram 
positive organisms were treated similar to the control group. 
All treated animals were tested and showed negative for 
milk antibiotic residue screening tests before their milk was 
allowed into the bulk tank for commercial purposes. Aseptic 
quarter milk samples of all animals were tested again at 
approximately fourteen and twenty-eight days postcalving 
to evaluate infection dynamics, spontaneous cures, 
treatment success, and new infections. Any cows with 
quarters showing clinical mastitis were not used for this 
portion of the study.  
 Clinical Mastitis Protocol: Animals that developed 
clinical mastitis at any point during lactation (including at 
calving) were used in this trial. Clinical mastitis cows were 
identified by the milkers, and flagged for later evaluations. 
A CMT was performed and aseptic milk samples were taken 
from all CMT positive and/or clinical quarters. Samples 
were cultured similarly to the Fresh Cow Study. Mastitis 
cases were graded as follows: Grade 1 – visual 
abnormalities in milk only; Grade 2 – local gland 
abnormalities along with milk abnormalities; and Grade 3 – 
systemic signs or abnormalities in addition to milk and 
udder abnormalities. All grade 3 mastitis cases were treated 
symptomatically based on treatment protocols and 
recommendations of the ISU herd veterinarian, and were not 
included in the study. Quarters with Grade 1 or 2 mastitis 
were randomly assigned to one of two treatment groups. 
Quarters in the control group were treated immediately 
following initial evaluation using the appropriate 
antimicrobial (see fresh cow protocol). Quarters in the 
second wait group were not treated until culture results were 
available twenty-four hours post evaluation, with the 
treatment regime being similar to the fresh cow protocol. 
See figure 2. Other bacteriological analysis and data capture 
were similar to the fresh cow group.  
 CMT and culture data at calving was analyzed using a 
chi-square procedure. Sensitivity, specificity, positive 
predictive value, and negative predictive values were 
generated for the CMT at calving as well. Cure rates for 
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each group were also determined, along with new infection 
rate. A cure was considered to be achieved when a quarter 
that was culture positive at calving was culture negative 
upon subsequent testing fourteen days later. Likewise a new 
infection was defined as a quarter that had been culture 
negative at the previous test was now culture positive. Cost-
benefit analysis was also performed for each group. Costs 
for therapy included antimicrobials, labor, and milk discard. 
The cost of culturing an animal was determined using labor 
and material costs. 
 
Results 
 Results for the fresh cow trial are shown in Tables 1-3. 
Table 1 shows a summary of fresh animals and infection 
status by sample dates. A total of 66 animals that calved had 
complete data (46 cows, 20 heifers) with 28.3 and 70% of 
animals, and 8.9 and 34.2% of quarters infected at calving in 
cows and heifers, respectively.  Predominant organism in 
both groups was CNS and infection percentages were 
reduced into lactation as a result of therapy as well as 
spontaneous cure.  
 CMT sensitivity, specificity, and predictive values 
(PPV and NPV) for cows and heifers for each sample date 
are shown in table 2. Overall sensitivity and PPV were low 
for both cows and heifers indicating the CMT made not be 
very good at identifying truly infected animals. Both high 
specificity and, especially, NPV substantiate that the CMT 
is an excellent tool to identify non-infected quarters and 
animals. Results were reasonably similar between heifers 
and cows, but heifers seemed to have a stronger CMT 
reaction when infected with CNS as compared to cows. 
 Treatment results for the fresh cow trial are shown in 
table 3. Overall, a high percentage of CMT positive quarters 
were culture negative, resulting in a high percentage of 
uninfected control quarters being treated. Cure rates for 
treated infected quarters did not different between control 
and wait group, or heifer and cow groups. 
     Results for the clinical mastitis trial are shown in tables 
4-5. Table 4 shows a summary of clinical mastitis animals 
and infection status by sample dates. Most clinical mastitis 
was associated with environmental pathogens (streps. and 
gram negatives) or no growth. Clinical mastitis treatment 
results are shown in table 5. Over 50% of clinical cases 
showed no growth and resulted in a high percentage of these 
being treated in the control group. There were no 
differences in cure rates between groups.  
 A partial budget with costs and assumptions for both 
the fresh cow and clinical mastitis trials is shown in Table 6. 
Costs associated with treating fresh cows were similar 
between control (treat immediately) and wait (24 hour, 
culture) groups. Although the control group treated more 
uninfected cows, the wait group incurred milk discard costs 
as the 24 hour lag resulted in dumping saleable milk. 
Waiting 24 hours to treat and culturing resulted in much 
lower overall costs compared to treat immediately for 
clinical mastitis cows, primarily as a result of the high 
percentage of clinical cows that were culture negative. 
 Cure rates in both the fresh and clinical animals did not 
change when treatment was delayed for twenty-four hours 
while waiting for culture results (tables 3 and 5). This would 
indicate that waiting for culture results before instituting 
treatment does not affect treatment success. The on-farm 
culture system, in conjunction with the CMT, dramatically 
reduced the number of animals treated with antimicrobials 
as compared to basing treatment decisions off of the CMT 
or clinical symptoms only. In fresh animals the cost of 
waiting to treat animals and treating animals immediately 
was nearly equal. Although fewer animals were treated in 
the wait group, the cost of culturing and additional dump 
milk off-set the savings from treating fewer animals. 
However, this could change greatly based on labor and milk 
price and this does not take into account a reduction in 
potential antimicrobial residue risks. In clinical animals 
there was immense savings in culturing animals and only 
treating those necessary. Clinical situations that do not occur 
at calving are different than fresh cow mastitis because the 
amount of milk dumped during treatment is significantly 
greater, and the amount of milk dumped is the same 
regardless of when treatment is instituted. Since this is the 
case, spending a relatively small amount of money to 
perform a culture can result in larger savings because fewer 
animals are treated. The difference in the number of animals 
treated is enough that the reduced dump milk far offsets the 
cost of the culture. 
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Figure 1. Fresh cow CMT, culture, and treatment protocols. 
  
All Fresh Cows 
CMT and culture all quarters within 24 
hours of calving
CMT Negative CMT Positive
No Treatment  Random assignment to one of 
two treatment groups
Wait Group 
(W)
Control Group 
(C)
Treat quarter(s) with Pirsue® for 
two treatments 24 hours apart.1
1 If Pirsue® does not work after two days, or if susceptibility results show the organism is resistant to 
Pirsue®, the antibiotic will be switched. 
-All animals will be rechecked at 14 & 28 days post-calving. 
Wait 24 hours for 
culture results
Treat quarter(s) with Pirsue® for 
two treatments 24 hours apart. 
No growth or Gram 
(-) Gram (+)
No Treatment 
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Figure 2. Clinical mastitis CMT, culture, and treatment protocols. 
 
 
  
 
 
Table 1. Summary of fresh animals and infection status by sample dates. 
 
Summary of Fresh Animal Infections by Sample 
 Calving  2 Weeks Post-Calving  4 Weeks Post-Calving 
 Cows Heifers Cows Heifers Cows Heifers 
Number of Animals 46 20 44 20 37 16 
% Animals Infected 28.3% 70% 25.0% 55.0% 19% 43.8% 
Number of Quarters 180 79 171 79 140 62 
Number (%) of 
 Quarters Infected 
19 
(8.9) 
27 
(34.2) 
12 
(7.0) 
17 
(21.5) 
7 
(5.0) 
11 
(17.7) 
Coagulase Negative 
Staphylococcus sp. 9 19 9 14 4 10 
Coagulase Positive 
Staphylococcus sp. 2 0 1 0 1 0 
Streptococcus sp. 6 6 1 0 1 0 
Other Gram Positives  0 1 1 1 1 1 
Gram Negative Species 2 1 0 2 0 0 
All cows with clinical 
mastitis*
CMT and culture quarters. 
Cows divided into two groups.
Control Group (C) Wait Group (W) 
Wait 24 hours for culture 
results. 
Treat quarter(s) with Pirsue® for two 
treatments 24 hours apart. 
Gram (-) or No 
Growth Gram (+) 
No treatment - 
Monito
The quarter(s) will be treated with 
Pirsue for two treatments, 24 hours 
a
r
part. 
* All cows with clinical mastitis will be evaluated systemically via rumen movement and temperature. Any cows with 
Grade III mastitis will be treated accordingly and not used as part of the study. 
1 If Pirsue® does not work after two days, or if susceptibility results show the organism is resistant to Pirsue®, the antibiotic 
will be switched. 
-All animals will be rechecked at 14 & 28 days post presentation. 
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 Table 2. CMT sensitivity, specificity, and predictive values (PPV and NPV) for cows and heifers for each sample date. 
 
Sensitivity & Specificity of Fresh Cow CMT 
 Sensitivity Specificity PPV NPV 
Calving Day 631(902)% 93(93)% 52(45)% 96(99)% 
14 Days Post-Calve 50(67)% 95(95)% 43(20)% 94(99)% 
28 Days Post-Calve 86(100)% 95(95)% 46(30)% 99(100)% 
 Sensitivity & Specificity of Fresh Heifer CMT 
 Sensitivity Specificity PPV NPV 
Calving Day 52(88)% 81(81)% 58(41)% 77(98)% 
14 Days Post-Calve 35(67)% 95(95)% 67(40)% 86(98)% 
28 Days Post-Calve 36(0)% 92(92)% 50(0)% 87(98)% 
 
1 all pathogens considered. 2 all pathogens with the exception of CNS. 
 
 
Table 3. Treatment results for the fresh cow trial. 
 
Treatment Results of Fresh Animal Infections 
 Cows Heifers 
 Control (Tx’d)1
Wait  
w/ Tx2
Wait 
No Tx3
Control 
(Tx’d) 
Wait  
w/ Tx 
Wait  
No Tx 
Number of  Animals 8 3 5 5 1 5 
Number of Quarters 13 4 6 8 3 10 
Culture Negative Quarters 5 - 64 - - 7 
Quarters w/ CNS 1 1 1 5 - 2 
CNS Quarters Cured 1 1 1 2 - 1 
Quarters w/ CPS 2 - - - - - 
CPS Quarters Cured - - - - - - 
Quarters w/ Strep. sp. 4 1 - 3 3 - 
Strep. sp. Quarters Cured 4 1 - 3 3 - 
Quarters w/ Gram Negative 1 - 15 - - 1 
Gram Negative 
Organisms Cured  1 - 1
5 - - 1 
 
1 Control (Tx’d) indicates animals in the control group - all CMT positive quarters were treated. 
2 Wait w/ Tx indicates animals that were in the wait 24 hours group, and received treatement. 
3 Wait No Tx indicates animals that were in wait 24 hr group, were culture negative, and did not receive treatment. 
4 One of these quarters was inadvertently treated, however, it should not have been. 
5 This animal was also inadvertently treated, her quarter cultured a gram negative organism, and it is was assumed that she 
would have cleared it on her own like the other without treatment.  
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Table 4.  Summary of clinical mastitis animals and infection status by sample dates. 
 
Summary of Clinical Infections by Sample 
 Initial Clinical Presentation  
2 Weeks Post-
Presentation  
4 Weeks Post-
Presentation 
 Cows Heifers Cows Heifers Cows Heifers 
Number of Animals 11 7 10 7 11 6 
Number of Quarters 43 28 38 28 41 23 
Number (%) Clinical 
Mastitis Quarters 
19 
(44.2) 
11 
(39.3) - - - - 
Number (%) of 
 Quarters Infected 
7 
(16.3) 
7 
(25.0) 
7 
(18.4) 
8 
(28.6) 
6 
(14.6) 
5 
(21.7) 
Coagulase Negative 
Staphylococcus sp. 4 1 4 5 6 3 
Coagulase Positive 
Staphylococcus sp. 0 0 0 0 0 0 
Streptococcus sp. 1 4 3 2 0 0 
Other Gram Positives  0 0 0 0 0 0 
Gram Negatives  2 2 1 1 0 2 
 
 
Table 5.  Clinical mastitis treatment results. 
 
Treatment Results of Clinical Animal Infections 
 Cows Heifers 
 Control (Tx’d) 
Wait  
w/ Tx 
Wait 
No Tx 
Control 
(Tx’d) 
Wait  
w/ Tx 
Wait  
No Tx 
Number of Animals 7 1 3 5 2 - 
Number of Quarters 11 2 4 8 3 - 
Culture Negative Quarters 6 2 4 4 1 - 
Quarters w/ CNS 2 - - 1 - - 
CNS Quarters Cured 1 - - 1 - - 
Quarters w/ CPS - - - - - - 
CPS Quarters Cured - - - - - - 
Quarters w/ Streps sp. 3 - - 2 2 - 
Streps sp. Quarters Cured 2 - - 2 1 - 
Quarters w/ Gram egative  - - - 1 - - 
Gram NegativesCured  - - - 1 - - 
 1 There are more control than wait animals because several wait group cows could not finish the 
  study for various reasons.   
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Table 6. Partial budgets with costs and assumptions for both the fresh cow and clinical mastitis trials. 
 
Partial Budget for Control & Wait Groups 
 Fresh  Control Fresh Wait Clinical Control Clinical Wait 
CMT 1.00 1.00 - - 
Culture1 - 3.75 - 3.75 
Antimicrobial2 9.503 8.004 8.005 7.506
Additional Dump Milk7 - 7.50 30.00 30.00 
Total per  
Animal 10.50 20.25 38.00 41.25 
Total Cost per 100 
Animals $199.50
8 $202.509 $285.0010 $99.0011
 
1 Cultures were assumed to be done in the parlor during milking time. Labor was assumed to be $10.00/hr, with a culture 
taking 10 minutes of total time. The rest of the cost is materials. 
2 The antimicrobial was two tubes of Pirsue®, which cost $5.00.  
3 In the fresh groups, on average, each treated animal had 1.9CMT (+) quarters (1.8x5). 
4 In the fresh wait group, on average, each infected animal had 1.6 infected quarters (1.6x5). 
5 In the clinical control group, on average, each treated animal had 1.6 clinical quarters (1.6x5). 
6 In the clinical wait group, on average, each infected animal had 1.5 infected quarters (1.5x5). 
7 Milk from all fresh animals is dumped for the first six milkings, only milk dumped beyond that was considered in the cost. 
For fresh cows, daily production was assumed to be 50 lbs/day, with milk being dumped for one extra day. For clinical 
cows, daily production was assumed to be the herd average of 80 lbs/day, with 2.5 days of milk being dumped. Milk was 
assumed to be $15/cwt. 
8 According to this studies results, 9% of quarters were CMT positive at calving, therefore,  
 400 quarters * 9% * 1/1.9 cow/quarters = ~19 animals treated.  
9 According to this study’s results, only 5% of quarters were bacteriologically positive, therefore, 
 400 quarters * 5% * 1/1.6 cow/quarters = ~10 animals treated. 
10 Approximately 3% of the herd showed clinical mastitis—all of which were treated in the control group, therefore, 400 
quarters *3% *1/1.6 cow/quarter = 7.5 animals. 
11 Approximately 3% of the herd showed clinical mastitis — but only ~30% were bacteriologically positive, therefore, 400 
quarters * 3% * 30% * 1/1.5 cow/quarters = 2.4 animals 
